Devbarna Sinha
  • Research Division, Peter MacCallum Cancer Centre, Australia, Australia,
Research fields
  • Cancer biology
Personal information


PhD, Australian National University, Australia

Current position

Not applicable, Not applicable, Not applicable, Not applicable


  1. Yeh, P., Hunter, T., Sinha, D., Ftouni, S., Wallach, E., Jiang, D., Chan, Y.-C., Wong, S. Q., Silva, M. J., Vedururu, R., Doig, K., Lam, E., Arnau, G. M., Semple, T., Wall, M., Zivanovic, A., Agarwal, R., Petrone, P., Jones, K., Westerman, D., Blombery, P., Seymour, J. F., Papenfuss, A. T., Dawson, M. A., Tam, C. S. and Dawson, S.-J. (2017). Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia. Nature Communications 8: 14756. 

  2. Yeh, P., Dickinson, M., Ftouni, S., Hunter, T., Sinha, D., Wong, S. Q., Agarwal, R., Vedururu, R., Doig, K., Fong, C. Y., Blombery, P., Westerman, D. and Dawson, M. A. (2017). Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes. Blood 129(12): 1685-1690. 

  3. Sinha, D., Chong, L., George, J., Schluter, H., Monchgesang, S., Mills, S., Li, J., Parish, C., Bowtell, D., Kaur, P. and Australian Ovarian Cancer Study, G. (2016). Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients. Clin Cancer Res 22(7): 1813-1824. 

  4. Fong, C. Y., Gilan, O., Lam, E. Y. N., Rubin, A. F., Ftouni, S., Tyler, D., Stanley, K., Sinha, D., Yeh, P., Morison, J., Giotopoulos, G., Lugo, D., Jeffrey, P., Lee, S. C.-W., Carpenter, C., Gregory, R., Ramsay, R. G., Lane, S. W., Abdel-Wahab, O., Kouzarides, T., Johnstone, R. W., Dawson, S.-J., Huntly, B. J. P., Prinjha, R. K., Papenfuss, A. T. and Dawson, M. A. (2015). BET inhibitor resistance emerges from leukaemia stem cells. Nature 525: 538. 

  5. Schluter, H., Stark, H. J., Sinha, D., Boukamp, P. and Kaur, P. (2013). WIF1 is expressed by stem cells of the human interfollicular epidermis and acts to suppress keratinocyte proliferation. J Invest Dermatol 133(6): 1669-1673.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.